NGVT
Get informed when a big investor buys or sells
+ FollowOvervalued by 79.8% based on the discounted cash flow analysis.
| Market cap | $2.54 Billion |
|---|---|
| Enterprise Value | $3.64 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.61 |
| Beta | 1.17 |
| Outstanding Shares | 35,000,000 |
| P/E Ratio | 47.47 |
|---|---|
| PEG | -38.26 |
| Price to Sales | 2.22 |
| Price to Book Ratio | 73.41 |
| Enterprise Value to Revenue | 3.14 |
| Enterprise Value to EBIT | 47.65 |
| Enterprise Value to Net Income | 67 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 25.59 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 18.71% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 3.60%▼ 97.04% |
|---|---|
| Total Invested | $88.88M▼ 96.53% |
| Investors Holding | 86▼ 221.00% |
No data
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...